Drug Type Monoclonal antibody |
Synonyms fully human anti-GPCR antibody (cancer)(Biocytogen Pharmaceuticals (Beijing) Co., Ltd.), fully human antibody targeting G protein-coupled receptor (cancer) |
Target |
Action antagonists |
Mechanism GPCR antagonists(G-protein coupled receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 01 Feb 2021 | |
Neoplasms | Preclinical | Japan | 01 Feb 2021 |